Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Open accessThe DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Invasive, life-threatening fungal infections are an important cause of morbidity and mortality, particularly for patients with compromised immune function. The number of therapeutic options for the treatment of invasive fungal infections is quite limited when compared with those available to treat bacterial infections. Indeed, only three classes of molecules are currently used in clinical practice and only one new class of antifungal drugs has been developed in the last 30 years. Here we summarize the unmet clinical needs of current antifungal therapy, discuss challenges inherent to antifungal drug discovery and development, and review recent developments aimed at addressing some of these challenges.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Organelles such as the vacuole make important contributions to tolerance and/or trailing growth.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [94]
In the citing paper
“In Saccharomyces cerevisiae several genes involved in retrograde trafficking modulate tolerance and/or trailing growth, including VPS2127,51, VPS15 and VPS5194; Rim101 may influence tolerance via its ability to regulate the transcription of key components of the vacuolar trafficking pathway95.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [94]
In the citing paper
“Despite extensive efforts, target-based cell-free screening of synthetic chemical libraries has failed to deliver any new classes of antifungals or antibacterials in clinical practice (Payne et al., 2007; Roemer and Krysan, 2014).”
From A Fungal-Selective Cytochrome bc1 Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance (2016) · cites this paper as Roemer and Krysan, 2014
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Functional profiling of the Saccharomyces cerevisiae genome
Giaever, G., Chu, A. M., Ni, L., Connelly, C., Riles, L., Véronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., André, B., et al. (2002) · Nature · doi:10.1038/nature00935 · Cited by 4,316
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
The Genetic Landscape of a Cell
Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L. Y., Toufighi, K., Mostafavi, S., et al. (2010) · Science · doi:10.1126/science.1180823 · Cited by 2,162
Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,014
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Pierce, C. G., Uppuluri, P., Tristan, A. R., Wormley, F. L., Mowat, E., Ramage, G., & Lopez-Ribot, J. L. (2008) · Nature Protocols · doi:10.1038/nprot.2008.141 · Cited by 1,041
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Cited by
Items 301–400 of 620
Du, W., Xu, R., He, Z., Yang, H., Gu, Y., & Liu, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1089267 · Cited by 14
Alam, M. S., & Ahmed, J. U. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136504 · Cited by 12
Meleddu, R., Distinto, S., Corona, A., Maccioni, E., Arridu, A., Melis, C., Bianco, G., Mátyus, P., Cottiglia, F., Sanna, A. M., et al. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1113171 · Cited by 14
A High-Throughput Candida albicans Two-Hybrid System
Schoeters, F., Munro, C. A., d’Enfert, C., & Dijck, P. V. (2018) · mSphere · doi:10.1128/msphere.00391-18 · Cited by 13
Klesiewicz, K., Żelaszczyk, D., Trojanowska, D., Bogusz, B., Małek, M., Waszkielewicz, A. M., Szkaradek, N., Karczewska, E., Marona, H., & Budak, A. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13356 · Cited by 12
Lev, S., Li, C., Desmarini, D., Sorrell, T. C., Saiardi, A., & Djordjevic, J. T. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00248 · Cited by 12
Muthukrishnan, P., Chithra Devi, D., Mostafa, A. A.-F., Alsamhary, K. I., Abdel-Raouf, N., & Sholkamy, E. N. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.06.025 · Cited by 12
Pippi, B., Joaquim, A. R., Merkel, S., Zanette, R. A., Nunes, M. E. M., Silva, D. G. D. C., Schimith, L. E., Teixeira, M. L., Franco, J. L., de Andrade, S. F., et al. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14915 · Cited by 12
Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents
Balestri, L. J. I., D’Agostino, I., Rango, E., Vagaggini, C., Marchitiello, R., Mariotti, M., Casian, A., Deodato, D., Truglio, G. I., Orofino, F., et al. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10388-7 · Cited by 12
Ahmed, S., Manning, A. J., Flint, L., Awasthi, D., Ovechkina, Y., & Parish, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.790583 · Cited by 13
Jha, A., & Kumar, A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0479 · Cited by 12
Stoyanova, M., Gledacheva, V., & Nikolova, S. (2025) · Applied Sciences · doi:10.3390/app15126441 · Cited by 18
Fluorescent toys ‘n’ tools lighting the way in fungal research
Genechten, W. V., Dijck, P. V., & Demuyser, L. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab013 · Cited by 16
Luna-Tapia, A., Parker, J. E., Kelly, S. L., & Palmer, G. E. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01044-21 · Cited by 14
Ma, H., Qian, A., Zheng, Y., Meng, X., Wang, T., Zhang, Y., Sun, L., Zou, F., Zhao, B., Zhang, S., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02227 · Cited by 12
The Use of Host Biomarkers for the Management of Invasive Fungal Disease
Griffiths, J. S., Orr, S. J., Morton, C. O., Loeffler, J., & White, P. L. (2022) · Journal of Fungi · doi:10.3390/jof8121307 · Cited by 11
Izadi, A., Paknia, F., Roostaee, M., Mousavi, S. A. A., & Barani, M. (2024) · Nanotechnology · doi:10.1088/1361-6528/ad4bed · Cited by 13
Ibe, C., Walker, L. A., Gow, N. A. R., & Munro, C. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_16 · Cited by 12
Rathore, S. S., Muthukrishnan, I., Sridharan, V., Chellappan, D. R., Cheepurupalli, L., Raman, T., & Ramakrishnan, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-15500-8 · Cited by 11
Mohammed, F. A., Razvi, S. S., Abdul, W. M., Mohammed, K., Hakeem, K. R., Banaganapalli, B., Shaik, N. A., & Elkady, A. I. (2019) · Springer eBooks · doi:10.1007/978-3-030-04408-4_8 · Cited by 11
Setting New Routes for Antifungal Drug Discovery Against Pathogenic Fungi
Silva, K. S. F. E., Silva, L. D. C., Gonçales, R. A., Neves, B. J., Soares, C. M. D. A., & Pereira, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200317125956 · Cited by 12
Combination therapy against human infections caused by Candida species
Maurya, I. K., Semwal, R. B., & Semwal, D. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820576-1.00004-7 · Cited by 11
Brown, A. J. P., Cowen, L. E., Pietro, A. D., & Quinn, J. (2017) · ASM Press eBooks · doi:10.1128/9781555819583.ch21 · Cited by 15
Zhou, X., Yang, G., Li, C., Yang, F., & Chang, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.957857 · Cited by 11
Hunsaker, E. W., McAuliffe, K. J., & Franz, K. J. (2020) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-020-01796-x · Cited by 12
Khapuinamai, A., Rudraprasad, D., Pandey, S., Gandhi, J., Mishra, D. K., & Joseph, J. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.4.44 · Cited by 10
Barbarossa, A., Rosato, A., Carrieri, A., Fumarola, L., Tardugno, R., Corbo, F., Fracchiolla, G., & Carocci, A. (2024) · Pharmaceuticals · doi:10.3390/ph17091109 · Cited by 10
Synthesis and Biological Evaluation of Hippolachnin A Analogues
Timmerman, J. C., & Wood, J. L. (2018) · Organic Letters · doi:10.1021/acs.orglett.8b01381 · Cited by 10
Radaković, N., Nikolić, A., Terzić, N., Stojković, P., Stankovic, N., Šolaja, B. A., Opsenica, I., & Pavić, A. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114137 · Cited by 10
Molina, E., García-Gutiérrez, L., Junco, V., Pérez‐Olivares, M., de Yébenes, V. G., Blanco, R. E., Quevedo, L., Acosta, J. C., Marín, A. V., Ulgiati, D., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02846-9 · Cited by 11
Zhong, X., Liu, S., Zhang, C.-W., Zhao, Y.-S., Sayed, A., Rajoka, M. S. R., He, Z.-D., & Song, X. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100383 · Cited by 19
Fattouh, N., Khalaf, R. A., & Husni, R. (2024) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2024.02.012 · Cited by 10
Klimas, F., Zatłoka-Mazur, D., Rusiński, K., Zając, P., Pawłowski, B., Sienkiewicz, M., Potoczek, A., Zięba, Z., & Pudełko, I. (2025) · Quality in Sport · doi:10.12775/qs.2025.38.57928 · Cited by 10
Hussain, A., & Verma, C. K. (2021) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.15.2.49 · Cited by 10
Dhandapani, K., Sivarajan, K., Ravindhiran, R., & Sekar, J. N. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.887971 · Cited by 10
Veeraswamy, S. D., Ilavarasan, R., & Mohan, S. (2022) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2544 · Cited by 11
The role of methionine synthases in fungal metabolism and virulence
Scott, J., & Amich, J. (2023) · Essays in Biochemistry · doi:10.1042/ebc20230007 · Cited by 11
Pinheiro, A. M., Carreira, A., Rollo, F., Fernandes, R., Ferreira, R. B., & Monteiro, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01803 · Cited by 10
Multiple Drug Targeting Potential of Novel Ligands Against Virulent Proteins of Candida albicans
Jha, A., & Kumar, A. (2019) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-019-09897-1 · Cited by 10
Lanez, T., Lanez, M., Lanez, R., Lanez, E., & Talbi-Lanez, B. (2024) · Current Drug Discovery Technologies · doi:10.2174/0115701638326365241029080310 · Cited by 11
Wu, Z., Wu, Q., Yuan, W., Chen, Y., Hu, D., Deng, D., Zhang, L.-L., & Niu, X. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04051-22 · Cited by 9
Pharmaceutical salts of azole anti-fungal drugs: physicochemical behaviour and activity studies
Qadri, H., Malik, A. A., Ahangar, A. A., Mir, M. A., Dar, A. A., & Shah, A. H. (2024) · RSC Pharmaceutics · doi:10.1039/d4pm00003j · Cited by 9
Investigation of aryl isonitrile compounds with potent, broad-spectrum antifungal activity
Mohammad, H. T., Kyei‐Baffour, K., Younis, W., Davis, D. C., Eldesouky, H. E., Seleem, M. N., & Dai, M. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.03.035 · Cited by 10
Vélez, V., González‐Crespo, S., Santiago, E., Vázquez-Quiñones, L. E., Martínez, N., Otero, Y., Zayas, J. J., Siaca, R., del Rosario, J., Mejías, I., et al. (2020) · G3 Genes Genomes Genetics · doi:10.1534/g3.120.401468 · Cited by 10
Laser-Assisted Delivery of Molecules in Fungal Cells
McGraw, E., Dissanayaka, R., Vaughan, J. C., Kunte, N., Mills, G., Laurent, G. M., & Avila, L. A. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00720 · Cited by 9
Nguyen, P.-T., Toh‐e, A., Nguyen, H. N., Imanishi, Y., Watanabe, A., Kamei, K., & Shimizu, K. (2020) · Current Genetics · doi:10.1007/s00294-020-01112-9 · Cited by 9
Perturbation of Alphavirus and Flavivirus Infectivity by Components of the Bacterial Cell Wall
Langendries, L., Jacobs, S., Abdelnabi, R., Verwimp, S., Kaptein, S. J. F., Baatsen, P., Mellaert, L. V., & Delang, L. (2022) · Journal of Virology · doi:10.1128/jvi.00060-22 · Cited by 9
Gong, Y., Li, H., Wu, F., Li, Y., & Zhang, S. (2022) · Biomolecules · doi:10.3390/biom12070965 · Cited by 9
Fenley, J. D. C., de Barros, P. P., do Carmo, P. H. F., Garcia, M. T., Rossoni, R. D., & Junqueira, J. C. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44110364 · Cited by 10
Kerstens, W., Kremer, A., Holtappels, M., Borghgraef, P., Lippens, S., & Dijck, P. V. (2020) · mSphere · doi:10.1128/msphere.00981-19 · Cited by 9
Cao, Y., Ni, J., Ji, W., Shang, K., Liang, K., Lu, J., Bi, Y., & Luo, X. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0289 · Cited by 9
Ramírez‐Amador, V., Patton, L. L., Naglik, J. R., & Nittayananta, W. (2020) · Oral Diseases · doi:10.1111/odi.13391 · Cited by 11
Jothi, R., Hong, S., Enkhtsatsral, M., Pandian, S. K., & Gowrishankar, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295922 · Cited by 8
Impact of Nitric Oxide-Release Kinetics on Antifungal Activity
Grayton, Q. E., Conlon, I. L., Broberg, C. A., & Schoenfisch, M. H. (2024) · Journal of Fungi · doi:10.3390/jof10050308 · Cited by 8
A novel pH-responsive monomer inhibits Candida albicans via a dual antifungal mode of action
Li, H., Shi, Y., Chen, H., Liang, J., Zhang, S., Li, B., Chen, J., Li, M., Peng, X., Zhou, X., et al. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00851k · Cited by 8
Wu, J.-Y., Li, L., Chen, M., Liu, M., Zeng, M., & Tu, W. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.125580 · Cited by 10
Meghdadian, M., & Mahmoodi, N. M. (2025) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2025.117718 · Cited by 8
Potshangbam, A. M., Rathore, R. S., Prabhu, N. P., & Vindal, V. (2016) · SpringerPlus · doi:10.1186/s40064-016-2589-3 · Cited by 8
Evaluation of the activity of Tontelea micrantha extracts against bacteria, Candida and Mayaro virus
de Magalhães, J. C., Nizer, W. S. D. C., Ferraz, A., Lima, W. G., Moraes, T. D. F. S., Ferreira, F. L., Ferreira, J. S., Magalhães, C. L. D. B., Duarte, L. P., & Filho, S. V. (2018) · Journal of Pharmaceutical Negative Results · doi:10.4103/jpnr.jpnr_8_18 · Cited by 8
Araújo, D. E., de Oliveira, A. A., Cabral, M. S., Costa, A. F., Silva, B. C., Silva, L. D. C., de Menezes, L. B., Soares, C. M. D. A., Amaral, A. C., & Pereira, M. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00326-w · Cited by 9
A Novel Strategy to Identify Haematology Patients at High Risk of Developing Aspergillosis
Griffiths, J. S., White, P. L., Thompson, A., da Fonseca, D. M., Pickering, R. J., Ingram, W. A., Wilson, K. M. O., Barnes, R. A., Taylor, P. R., & Orr, S. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.780160 · Cited by 8
Puumala, E., Zaslaver, O., Chen, A., Duncan, D., Fogal, M., Shapiro, R. S., Mazhab‐Jafari, M. T., Whitesell, L. J., Montenegro-Burke, J. R., Robbins, N., et al. (2022) · mBio · doi:10.1128/mbio.02730-22 · Cited by 9
Kitisin, T., Muangkaew, W., Ampawong, S., Sansurin, N., Thitipramote, N., & Sukphopetch, P. (2022) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.359437 · Cited by 8
Sosnik, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50878-0.00001-x · Cited by 11
A Comprehensive Appraisal of Chalcones and Their Heterocyclic Analogs as Antimicrobial Agents
Salotra, R., & Utreja, D. (2020) · Current Organic Chemistry · doi:10.2174/1385272824999200922090524 · Cited by 8
Human Fungal Pathogens: Diversity, Genomics, and Preventions
Fahliyani, S. A., Rastegari, A. A., Yadav, N., & Yadav, A. N. (2021) · Fungal biology · doi:10.1007/978-3-030-60659-6_16 · Cited by 9
Singh, U., Laxmi, L., Singh, P., Singh, A. K., Singh, S., Kumar, D., Shrivastava, S. K., & Asthana, R. K. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2115556 · Cited by 11
Victor, M. M., Farias, R. R., da Silva, D. L., do Carmo, P. H. F., de Resende, M. A., Viegas, C., Espuri, P. F., & Marques, M. J. (2018) · Medicinal Chemistry · doi:10.2174/1573406414666181024111522 · Cited by 8
Rollin‐Pinheiro, R., de Moraes, D., Bayona-Pacheco, B. L., Curvelo, J. A. D. R., dos Santos, G. M. P., Xisto, M. I. D. D. S., Borba-Santos, L. P., Rozental, S., Ferreira‐Pereira, A., & Barreto‐Bergter, E. (2023) · Journal of Fungi · doi:10.3390/jof9111115 · Cited by 8
Retinoids as Alternative Antifungal Agents Against Candida albicans: In Vitro and In Silico Evidence
Cosio, T., Romeo, A., Pistoia, E. S., Pica, F., Freni, C., Iacovelli, F., Orlandi, A., Falconi, M., Campione, E., & Gaziano, R. (2025) · Microorganisms · doi:10.3390/microorganisms13020237 · Cited by 7
Lupeol mitigates biofilm formation and attenuates virulence dimorphism in Candida albicans
Jothi, R., Malligarjunan, N., Vidhya, K., Sangavi, R., Kamaladevi, A., Veerapandian, R., Rengasamy, K. R. R., Pandian, S. K., & Gowrishankar, S. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107989 · Cited by 7
Zhang, M., Wang, M.-Y., Yu, Y., Meng, S.-S., Yan, C.-W., Zhiyong, W., & Li, Y. (2023) · CrystEngComm · doi:10.1039/d3ce00082f · Cited by 7
Jain, T., Mishra, P., Kumar, S., Panda, G., & Banerjee, D. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.994873 · Cited by 8
Tiwari, A., Tiwari, V., Palaria, B., Aslam, R., Kumar, M., & Kumar, N. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2280779 · Cited by 7
Synthesis and Antifungal Activity of Stereoisomers of Mefloquine Analogs
Guin, S., Alden, K. M., Krysan, D. J., & Meyers, M. J. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00031 · Cited by 7
Self-citationIshita, K., Stefanopoulos, S., Khalil, A., Cheng, X., Tjarks, W., & Rappleye, C. A. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.01.024 · Cited by 10
Biosynthesis and Mechanism of Action of Antifungal Peptidyl Nucleoside Natural Products
Draelos, M. M., & Yokoyama, K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14680-3 · Cited by 8
Berkes, C. A., Franco, J., Lawson, M., Brann, K., Mermelstein, J., Laverty, D. J., & Connors, A. (2021) · Antibiotics · doi:10.3390/antibiotics10101223 · Cited by 7
Dumesic, P. A., Rosenblad, M. A., Samuelsson, T., Nguyen, T. T. M., Moresco, J. J., Yates, J. R., & Madhani, H. D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv819 · Cited by 7
Mandras, N., Roana, J., Scalas, D., Fucale, G., Allizond, V., Banche, G., Barbui, A. M., Vigni, N. L., Va, N., Cuffini, A., et al. (2015) · PubMed · Cited by 7
Malhotra, S., Singh, S., Rana, N., Tomar, S., Bhatnagar, P., Gupta, M., Singh, S. K., Singh, B. K., Chhillar, A. K., Prasad, A. K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00273-17 · Cited by 7
Programmed cell death in human pathogenic fungi – a possible therapeutic target
Leiter, É., Csernoch, L. J., & Pócsi, I. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1541087 · Cited by 7
Vallières, C., Alexander, C., & Avery, S. V. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11211-3 · Cited by 7
Zhou, R., Dzomba, P., & Gwatidzo, L. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00565-2 · Cited by 6
Kannan, K. P., & Girija, A. S. S. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01469-w · Cited by 7
Molecular recognition of fungal methylated glucosylceramides by ETD151 defensin
Kharrat, O., Paquet, F., Nasreddine, R., Madinier, J., Nehmé, R., Aucagne, V., Bulet, P., Warschawski, D. E., & Landon, C. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110587 · Cited by 7
Antifungal toxicity of linear geranylphenol. Influence of oxigenate substituents
Taborga, L., Sortino, M. A., Carrasco, H., Butassi, E., Zacchino, S. A., & Espinoza, L. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.05.027 · Cited by 6
Recent Advances in the Development of Coumarin Derivatives as Antifungal Agents
Sharma, R. K., & Katiyar, D. (2019) · Springer eBooks · doi:10.1007/978-981-13-9435-5_10 · Cited by 8
Molecular Docking Evaluation of the Desert Truffles as Potent Antifungal Inhibitors
Al-Mazaideh, G. M., Alswailmi, F. K., & Parrey, M. U. R. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i531179 · Cited by 6
Chua, S. M. H., Wizrah, M. S. I., Luo, Z., Lim, B. Y. J., Kappler, U., Kobe, B., & Fraser, J. A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101091 · Cited by 6
Devi, A. P., Dhingra, N., Bhardwaj, U., Chundawat, R. S., Joshi, C. K., Singh, S., & Ameta, K. L. (2021) · Current Research in Green and Sustainable Chemistry · doi:10.1016/j.crgsc.2021.100234 · Cited by 8
Liu, Y., Jiao, Y., Quan, Y., Li, M., Huang, X., Jin, J., Li, S., Quan, J., & Jin, C. H. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202400135 · Cited by 7
Whole-Genome Approach to Understanding the Mechanism of Action of a Histatin 5-Derived Peptide
Bullock, C. B., McNabb, D. S., & Pinto, I. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01698-19 · Cited by 7
Wang, J., & Zhu, H. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111998 · Cited by 6
In vivo veritas: Aspergillus fumigatusproliferation and pathogenesis – conditionally speaking
Cramer, R. A. (2015) · Virulence · doi:10.1080/21505594.2015.1134074 · Cited by 6
Kumar, G., Kalita, A. H., Ahmed, J., Saxena, S., Sharma, S., Mehta, A., Sharma, A., Kurmi, B. D., Gupta, G. D., & Thakur, S. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04268-8 · Cited by 7
Stoyanova, M., Gledacheva, V., Milusheva, M., Todorova, M. M., Kircheva, N., Angelova, S., Stefanova, I. D., Pencheva, M. M., Tumbarski, Y. D., Vasileva, B., et al. (2025) · Nanomaterials · doi:10.3390/nano15110815 · Cited by 5
Employing machine learning for identifying antifungal compounds against Candida albicans
de Souza, D. R., Silva, L. D. C., Silva, K. S. F. E., de Jesus, F. S., de Oliveira, A. A., Neves, B. J., & Pereira, M. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2525717 · Cited by 6
Regan, J., DeJarnette, C. A., Luna-Tapia, A., Parker, J. E., Reitler, P., Barnett, S., Tucker, K. M., Kelly, S. L., & Palmer, G. E. (2022) · mBio · doi:10.1128/mbio.00115-22 · Cited by 5
Dowdy, H., Kumar, R. S., Almansour, A. I., Arumugam, N., Alaqeel, S. I., & Thangamani, S. (2022) · Pathogens and Disease · doi:10.1093/femspd/ftac013 · Cited by 5
Metadata
- Authors
- Roemer, T., & Krysan, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Rochester Medicine (US)
- ORCID
- Krysan, D. J.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-05-01
- Volume
- 4
- Issue
- 5
- Pages
- a019703-a019703
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC3996373
- OpenAlex
- W2134122507
- Cited by
- 593
- References
- 78
- Citations by year
- 2026: 39 · 2025: 56 · 2024: 69 · 2023: 51 · 2022: 58 · 2021: 68 · 2020: 71 · 2019: 42 · 2018: 50 · 2017: 38 · 2016: 30 · 2015: 18 · 2014: 3
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Rochester
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI097142, R01AI091422)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- antifungal drug development, invasive fungal infections, antifungal drug discovery, unmet clinical needs, immunocompromised patients
- MeSH terms
- Antifungal Agents, Forecasting, Humans, Mycoses, Technology, Pharmaceutical, Treatment Outcome, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.